Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH

• Status: Completed
• Trial end date: 2007-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this research is to explore ways to improve and simplify control of blood pressure in patients with SAH or ICH. This research will be done by comparing tow different medications that are routinely used to help control blood pressure. None of the medications used in this study nor any procedures performed are experimental.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Illinois at Chicago
• Treatments: Nicardipine

Criteria

Inclusion Criteria:

• 18-70 years old (inclusive)

• Admission to NSICU with a diagnosis of SAH or ICH

Exclusion Criteria:

• Patients who are admitted >48 hours after SAH or ICH

• Readmission or second SAH

• Readmission or second ICH

• Large (immediately life threatening) associated intraparenchymal or intraventricular hemorrhage

• Women who are pregnant